UK Approval For Seretide MDI: Cipla

301 views · Published 27 December 2016 · 7:20 · Indexed 26 October 2026

Channel: NDTV · 2016 · News & Politics

Watch on YouTube

Kedar Upadhye, global CFO of Cipla, says the company has received approval for the Seretide MDI inhaler.  This is a market with a $200 million size as Cipla will be the second generics player in the UK market, he adds.
Watch more videos:  http://ndtv.com/videos?yt 
Download the NDTV news app: 
https://play.google.com/store/apps/details?id=com.july.ndtv&referrer=utm_source%3Dyoutubecards%26utm_medium%3Dcpc%26utm_campaign%3Dyoutube

More from this channel